Why Pharmaceutical CRM Is Low and How It Can Be Changed

Even after pharmaceutical companies have invested plenty in new technologies, their ROI is still poor due to poor assessment of customer requirements. CRM implementation and integration levels within an enterprise are often limited by businesses very often.
At the same time, businesses fail to realize that CRM is as much about employee skills and business processes being changed as it is with regard to technology.

Research shows that the integration between analytical and operational CRM will be greater in the future. There will be a vast change in the development, packaging and marketing of CRM to the pharmaceutical industry due to the need for real time analytics. Furthermore, due to the increased target of senior population, certain designated CRM activities will result around this segment. It has also been found that when the patient initiates contact is the strongest point for opportunities of CRM initiatives. They initiate contact when they are given facilities to research the disease and if they are given a free welcome pack with their prescription.

---

Useful Link

Pharmaceutical CRM